Ace and Tate Holding B.V.

Ace and Tate Holding B. V. is a Netherlands-based company specializing in stylish eyewear, including prescription glasses and sunglasses, aimed at fashion-conscious consumers who prioritize quality and design. Founded in 2013, Ace & Tate operates out of Amsterdam, Netherlands, focusing on the direct-to-consumer market for eyeglasses.

The company has conducted 2 deals, with the latest round of funding occurring on July 9, 2020, raising EUR 14. 25 million led by Rinkelberg Capital, with participation from Global Founders Capital and Investion. The company was co-founded by Camiel Van Bergen and Mark de Lange, who has not been noted for previous ventures. Ace & Tate does not have any reported subsidiaries or parent companies.

Ace & Tate specializes in offering high-quality prescription glasses and sunglasses, with prices for prescription frames starting at EUR 150. The company emphasizes customer satisfaction by providing incentives such as a 40% discount on additional frame purchases and free shipping on all orders. Their products cater to a diverse clientele across Europe, North America, and select regions in Asia, focusing on stylish and functional eyewear solutions. In the most recent fiscal year of 2023, Ace & Tate generated revenue amounting to EUR 60.

66 mn, with an EBITDA of EUR -7. 14 mn. The company follows a direct-to-consumer sales model emphasizing online transactions, which includes a 30-day return policy to enhance customer confidence. Ace & Tate plans to leverage the recent funding of EUR 14.

25 million, raised in July 2020, to enhance product offerings and expand into new markets. They are focusing on launching new eyewear designs and targeting expansion in Asia and North America by 2024. These strategies aim to increase market share and cater to a broader demographic while supporting their growth objectives.